查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768774

全球3D生物列印市場

3D Bioprinting
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球 3D 生物列印市場規模將達到 89 億美元

全球3D生物列印市場規模預計在2024年為37億美元，預計2030年將達到89億美元，2024年至2030年的複合年成長率為15.7%。報告分析的細分市場之一－噴墨列印市場，預計複合年成長率為16.3%，到分析期結束時規模將達到37億美元。磁浮市場在分析期間的複合年成長率預計為16.9%。

美國市場預計將達到10億美元，中國市場複合年成長率將達到14.8%

美國3D生物列印市場規模預計在2024年達到10億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到13億美元，在2024-2030年的分析期間內，複合年成長率為14.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為13.9%和13.0%。在歐洲，預計德國市場的複合年成長率為11.2%。

全球3D生物列印市場－主要趨勢與促進因素摘要

什麼是3D生物列印？

3D生物列印是一項突破性的技術，它將3D列印原理與生物科學相結合，用於創建功能性組織和器官。該過程涉及逐層沉積生物墨水（一種由活細胞和生物相容性材料製成的物質），以構建模擬人體組織生物複雜性的結構。 3D生物列印的第一步是數位設計階段，使用專用軟體創建組織或器官的模型。此數位藍圖使印表機能夠極為精確地放置生物墨水。生物墨水本身經過精心配製，可模擬人體細胞的自然環境，並促進其生長發育。列印後，建造的組織在受控環境中培養，有時由支架材料支撐，以使細胞成熟和組織化。 3D生物列印的潛在應用範圍非常廣泛，從皮膚移植物和軟骨的生產到肝臟和腎臟等更複雜的器官。隨著生物列印技術的發展，它有望克服傳統組織工程和器官移植方法面臨的許多限制。

3D生物列印將如何改變醫學和醫療保健？

3D生物列印對醫學和醫療保健的變革性影響已逐漸顯現，該技術已在多個關鍵領域提供革命性的解決方案。其中最重要的應用之一是器官移植，生物列印有望解決長期存在的捐贈器官短缺問題。研究人員在列印功能性、患者特異性器官（例如腎臟、心臟和肺臟）方面取得了突破。由於印刷的器官由接受者自身的細胞製成，因此可以顯著縮短等待時間並降低器官排斥風險。除了移植之外，3D生物列印還透過創建個人化組織植入（例如燒燙傷患者的皮膚和用於關節修復的軟骨）來增強再生醫學領域，從而加快康復並改善患者預後。該技術也對藥物測試和開發產生了重大影響。傳統上，製藥公司依靠動物模型進行臨床前試驗，但這些模型並不總是能準確預測人體反應。生物列印人體組織為藥物測試提供了更可靠的平台，有助於改進潛在治療方法的篩檢，並減少藥物開發平臺中代價高昂的後期失敗。隨著科技的進步，創造功能齊全的器官和個人化治療方法的潛力日益增強，並將深刻改變醫療保健模式。

3D 生物列印面臨哪些挑戰和倫理考量？

儘管3D生物列印應用前景廣闊，但它仍面臨著許多技術、倫理和監管挑戰，必須妥善應對才能充分發揮其潛力。主要的技術障礙之一是列印能夠在人體內存活並整合的功能性組織的複雜性。雖然皮膚和軟骨等簡單組織已成功生物列印，但肝臟和心臟等複雜器官的生物列印仍面臨重大挑戰。這些器官需要複雜的血管網路來確保所有部位的血液供應充足，而複製如此複雜的結構仍然是一項重大挑戰。此外，開發能夠精確複製人體組織各種機械和生物學特性的生物墨水仍是一個持續的研究領域。從倫理角度來看，列印人體組織的能力引發了許多擔憂。製造功能齊全的人體器官的可能性可能會引發圍繞人類克隆和人體組織商業化的爭論。此外，人們也擔心公平分配的問題，因為這項技術初期成本高昂，只有那些負擔得起的人才能使用，這可能會進一步加劇醫療保健的不平等。在監管方面，監管機構尚未適應生物列印帶來的獨特挑戰。與傳統醫療設備和藥品不同，生物列印的組織和器官介於生物製品和合成製品之間，這引發瞭如何在臨床廣泛應用之前確保其安全性和有效性的問題。應對這些挑戰對於3D生物列印技術的廣泛應用和倫理道德至關重要。

是什麼推動了 3D 生物列印市場的成長？

3D生物列印市場的成長受到多種因素的推動，所有這些因素都凸顯了多個行業對這項革命性技術日益成長的需求。技術進步在市場擴張中發揮關鍵作用。生物列印設備的創新，例如能夠列印更複雜設計的高解析度印表機，以及能夠更好地模擬人體組織的生物墨水配方的進步，不斷突破著可能性的界限。這些改進為醫療應用創造了新的可能性，吸引了公共和私營部門的投資。製藥公司也是成長的主要驅動力，因為他們正在利用生物列印來加速藥物研發和測試流程。該技術提供了一種更可靠、更具成本效益的替代方案，取代了通常依賴動物試驗且可能無法很好地應用於人體生物學的傳統方法。此外，與老化相關的慢性疾病和病症（例如心臟病和肝功能衰竭）的增多，正在推動對再生醫學解決方案的需求，而3D生物列印正在提供針對患者的個人化治療，從而改善治療效果。另一個關鍵因素是消費者對個人化醫療的偏好日益成長。隨著患者和醫療保健提供者越來越要求根據其個人基因圖譜量身定做治療方案，生物列印技術有望根據每位患者的獨特需求量身定做組織和器官。此外，政府資金的湧入以及與學術機構的合作正在推動該領域的研發，進一步加速生物列印技術的創新和商業化。這些趨勢表明，3D生物列印有望成為未來醫療保健領域不可或缺的一部分，其應用範圍涵蓋從器官移植到藥物開發等各個領域。

部分

技術（噴墨、磁浮、雷射、其他技術）、材料（生物細胞、水凝膠、細胞外基質、其他材料）、最終用戶（研究機構、學術機構、生物製藥公司、醫院）

受訪公司範例

  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical KK
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D SL
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP21002

Global 3D Bioprinting Market to Reach US$8.9 Billion by 2030

The global market for 3D Bioprinting estimated at US$3.7 Billion in the year 2024, is expected to reach US$8.9 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Inkjet-based, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Magnetic Levitation segment is estimated at 16.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 14.8% CAGR

The 3D Bioprinting market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.9% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global 3D Bioprinting Market - Key Trends and Drivers Summarized

What Is 3D Bioprinting and How Does It Work?

3D bioprinting is a groundbreaking technology that combines the principles of 3D printing with biological sciences to create functional tissues and organs. The process involves the layer-by-layer deposition of bio-inks, which are substances composed of living cells and biocompatible materials, to build structures that replicate the biological complexity of human tissues. The first step in 3D bioprinting is the digital design phase, where a model of the tissue or organ is created using specialized software. This digital blueprint guides the printer in placing bio-inks with extreme precision. The bio-inks themselves are carefully formulated to mimic the natural environment of human cells, promoting their growth and development. After printing, the constructed tissue is cultivated in a controlled environment to allow for cellular maturation and organization, sometimes supported by scaffolding materials. The potential applications of 3D bioprinting are vast, ranging from the production of skin grafts and cartilage to more complex organs like the liver and kidneys. As bioprinting technology evolves, it promises to overcome many of the limitations faced by traditional tissue engineering and organ transplantation methods.

How Is 3D Bioprinting Transforming Medicine and Healthcare?

The transformative impact of 3D bioprinting on medicine and healthcare is already becoming evident, with the technology offering revolutionary solutions in several key areas. One of the most significant applications is in organ transplantation, where bioprinting holds the promise of solving the chronic shortage of donor organs. Researchers are making strides in printing functional, patient-specific organs, such as kidneys, hearts, and lungs, which could drastically reduce waiting times and lower the risk of organ rejection, as the printed organs can be made from the recipient’s own cells. Beyond transplantation, 3D bioprinting is enhancing the field of regenerative medicine by enabling the creation of personalized tissue implants, such as skin for burn victims or cartilage for joint repair, that can accelerate recovery and improve patient outcomes. This technology is also having a profound effect on drug testing and development. Traditionally, pharmaceutical companies have relied on animal models for preclinical testing, but these models do not always accurately predict human responses. Bioprinted human tissues offer a more reliable platform for drug testing, allowing for better screening of potential treatments and a reduction in costly late-stage failures in drug development pipelines. As the technology advances, the potential for creating fully functional organs and personalized medical treatments will continue to grow, reshaping the healthcare landscape.

What Are the Challenges and Ethical Considerations in 3D Bioprinting?

Despite its promising applications, 3D bioprinting faces several technical, ethical, and regulatory challenges that need to be addressed for it to reach its full potential. One of the primary technical hurdles is the complexity of printing functional tissues that can survive and integrate into the human body. While simpler tissues like skin or cartilage have been successfully bioprinted, more complex organs such as the liver or heart pose significant challenges. These organs require intricate vascular networks to ensure a sufficient blood supply to all areas, and replicating such complex structures remains a major challenge. Moreover, the development of bio-inks that can accurately replicate the diverse mechanical and biological properties of human tissues is an ongoing area of research. Ethically, the ability to print human tissues raises a host of concerns. The potential for creating fully functional human organs could lead to debates over human cloning or the commodification of human tissues. Additionally, there is concern about the equitable distribution of this technology, as it may initially be prohibitively expensive and accessible only to those with the financial means, further exacerbating healthcare inequalities. On the regulatory side, governing bodies are still adapting to the unique challenges posed by bioprinting. Unlike traditional medical devices or pharmaceuticals, bioprinted tissues and organs straddle the line between biological products and synthetic materials, raising questions about how to ensure their safety and efficacy before they can be widely used in clinical settings. Addressing these challenges will be crucial to the widespread adoption and ethical use of 3D bioprinting technology.

What Are the Drivers Behind the Growth of the 3D Bioprinting Market?

The growth in the 3D bioprinting market is driven by several factors, all of which highlight the increasing demand for this revolutionary technology across multiple industries. Technological advancements are playing a critical role in the expansion of the market. Innovations in bioprinting equipment, such as higher resolution printers capable of more intricate designs, and advancements in bio-ink formulations that better mimic human tissues, are continuously pushing the boundaries of what can be achieved. These improvements have opened new possibilities in medical applications, attracting investment from both the public and private sectors. Pharmaceutical companies are also major drivers of growth, using bioprinting to accelerate drug discovery and testing processes. The technology offers a more reliable and cost-effective alternative to traditional methods, which often rely on animal testing that may not translate well to human biology. Additionally, the rise in chronic diseases and conditions associated with aging populations, such as heart disease and liver failure, is driving demand for regenerative medicine solutions, where 3D bioprinting offers patient-specific treatments that can improve outcomes. Another significant factor is the growing consumer preference for personalized medicine. Patients and healthcare providers are increasingly seeking treatments that are tailored to individual genetic profiles, and bioprinting offers the possibility of creating tissues and organs customized to each patient’s unique needs. Finally, the influx of government funding and partnerships with academic institutions has spurred research and development in the field, further accelerating innovation and the commercialization of bioprinting technologies. These trends indicate that 3D bioprinting is poised to become an integral part of the future of healthcare, with wide-ranging applications from organ transplantation to drug development.

SCOPE OF STUDY:

The report analyzes the 3D Bioprinting market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Inkjet-based, Magnetic Levitation, Laser-based, Other Technology); Material (Living Cells, Hydrogels, Extracellular Matrices, Other Materials); End-Use (Research Organizations & Academic Institutes, Biopharmaceutical Companies, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D S.L.
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • 3D Bioprinting - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Tissue Engineering Expands Market Opportunity for 3D Bioprinting
    • Technological Advancements in Bioinks Propel Growth in 3D Bioprinting Applications
    • Increasing Use of 3D Bioprinting in Drug Development and Testing Spurs Market Growth
    • Advances in Stem Cell Research Strengthen the Business Case for 3D Bioprinting in Regenerative Medicine
    • Growing Focus on Organ Transplantation Solutions Accelerates Demand for 3D Bioprinting
    • Here's the Story: Expanding Research in Cancer Therapeutics Drives Innovation in 3D Bioprinting
    • Increasing Application of 3D Bioprinting in Cosmetic Testing and Tissue Models Generates New Opportunities
    • Expanding Use of 3D Bioprinting in the Development of Complex Tissue Structures Strengthens Market Demand
    • Advances in Automation and Robotics Drive Efficiency in 3D Bioprinting Systems
    • Increasing Adoption of 3D Bioprinting in Academic and Research Institutes Expands Market Reach
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Living Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Living Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Extracellular Matrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Extracellular Matrices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Research Organizations & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Research Organizations & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World 3D Bioprinting Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Inkjet-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Inkjet-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Magnetic Levitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Magnetic Levitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Laser-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Laser-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • JAPAN
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • CHINA
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • EUROPE
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • FRANCE
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • GERMANY
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • UNITED KINGDOM
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • ASIA-PACIFIC
    • 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2025 & 2030

IV. COMPETITION